ProfileGDS4132 / 209528_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 45% 54% 42% 37% 50% 47% 39% 42% 32% 41% 35% 35% 40% 41% 39% 37% 39% 44% 33% 37% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101117.55745
GSM201543Muscle PCOS pioglitazone 121137.98954
GSM201544Muscle PCOS pioglitazone 161110.83742
GSM201545Muscle PCOS pioglitazone 201102.37937
GSM201829Muscle PCOS pioglitazone 231141.85750
GSM201830Muscle PCOS pioglitazon 251130.58247
GSM201831Muscle PCOS pioglitazone 271100.96639
GSM201832Muscle PCOS pioglitazone 31108.81742
GSM201833Muscle PCOS pioglitazone 4174.335332
GSM201834Muscle PCOS pioglitazone 81104.97141
GSM201835Muscle PCOS after pioglitazone 10274.789735
GSM201836Muscle PCOS after pioglitazone 12279.098735
GSM201837Muscle PCOS after pioglitazone 16286.633840
GSM201838Muscle PCOS after pioglitazone 20297.368941
GSM201839Muscle PCOS after pioglitazone 23293.738839
GSM201840Muscle PCOS after pioglitazone 25291.163837
GSM201841Muscle PCOS after pioglitazone 27285.31639
GSM201842Muscle PCOS after pioglitazone 3295.723544
GSM201843Muscle PCOS after pioglitazone 4279.993833
GSM201844Muscle PCOS after pioglitazone 8289.149637